Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
CIDRAP: RSV Can Trigger Invasive Pneumococcal Disease In Children, Study Finds
Respiratory syncytial virus (RSV) may trigger invasive pneumococcal disease (IPD) in some children, but its role in doing so varies across pneumococcal serotypes, according to a recent study in The Journal of Infectious Diseases. The findings are based on three continuous French surveillance systems on IPD, pneumococcal carriage and RSV infections from 2008 to 2023. The analysis included children younger than 15 years old. (Soucheray, 8/19)
MedPage Today: Low-Dose Hydrocortisone Led To Cognitive Benefits In Women With HIV
Low-dose hydrocortisone (LDH) improved aspects of cognition in women with virally suppressed HIV, a randomized trial showed. (Rudd, 8/18)
MedPage Today: FDA Approves Activin Signaling Inhibitor For Bone Disorder
The FDA approved garetosmab (Pasatru) to reduce the formation of new heterotopic ossification lesions and disease flares in adults with fibrodysplasia ossificans progressiva (FOP), the agency announced on Wednesday. (Ingram, 8/19)
Stat: Scientists Kept Brain Organoids Alive For Years. Then They Looked Inside
Harvard scientists feared ruining their oldest brain organoids. Instead, the tiny models kept developing, revealing a remarkable internal clock. (Molteni, 8/19)
ScienceDaily: Scientists Turn Probiotic Bacteria Into Tiny Drug Factories For Pancreatic Cancer
Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy. (8/19)
MedPage Today: This Fetus Had A Parasitic Twin In An Unusual Location
The extremely rare palatal fetus-in-fetu proved challenging for the medical team. (Firth, 8/17)
